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ABSTRACT 
Christian M. Johnson:  Craniofacial Characterization of Patients with Marfan Syndrome 
(Under the direction of Sylvia Frazier-Bowers) 
 
Background:  Marfan Syndrome (MFS) is a life-threatening connective tissue disorder 
with an often elusive diagnosis.  Diagnosis is based on clinical findings outlined in the Ghent 
criteria which define hallmark features of the syndrome in the cardiovascular, ocular, and 
skeletal systems.  The morbidity and mortality associated with MFS warrant timely diagnosis 
and intervention that can improve long-term prognosis.  Previous research has highlighted the 
diagnostic value of craniofacial features in diagnosis; accordingly the aim of this study was to 
investigate craniofacial and dentoalveolar features in child, adolescent, and young adult patients 
with MFS.  We hypothesized that a distinct craniofacial morphology exists for patients with 
MFS that can be described quantitatively and qualitatively.  Methods:  Twenty subjects with a 
positive diagnosis of MFS were recruited for this study (N=20).  Craniofacial anthropometric 
measurements were made on each subject and compared to established norms of age- and sex-
matched controls.  The test measurements were compared to the control measurements by 
calculating a z-score for each test measurement; the measurements were categorized as normal or 
abnormal based on z-score.  Lateral and frontal photographs were obtained to make qualitative 
assessments and describe facial features of subjects, and a clinical exam was completed to 
document occlusal relationships.  Biometric and demographic information were obtained using a 
questionnaire.  Results:  The subjects were primarily female (60%) ranging in age between 4 to 
25 years (mean age 10.7±6.0years).  Comparison of craniofacial measurements revealed that for 
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9 of the 12 measurements, ≥65% of the study population had a z-score of ±2 and fell within the 
normal range for facial dimension.  For 3 of the 12 measurements, over half of the subjects fell 
outside of the normal range (z-score <-2 or >2) for facial dimension.  Assessment of the frontal 
and lateral photographs revealed the most prevalent facial features were retrognathia (54%) and 
down-slanting palpebral fissures (62%).  For occlusal relationships, 55% of subjects had a Class 
I molar relationship, 40% a Class II relationship, and 5% a Class III relationship.  Conclusion:  
Our data suggests there are quantitative differences in the facial morphology of patients with 
MFS when compared to a control population.   
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A REVIEW OF THE LITERATURE 
Marfan Syndrome 
Marfan Syndrome (MFS) is a life-threatening connective tissue disorder characterized by 
multi-system organ involvement.  The syndrome was first described by Dr. Antoine Marfan, a 
pediatrician, in 1896 at a meeting of the Medical Society of Paris1.  He presented a five-year-old 
girl with disproportionately long limbs that he described as arachnid-like1.  It wasn’t until almost 
fifty years later that the other hallmark cardiovascular and  ocular manifestations of the 
syndrome were described2.   
The cardinal features of MFS occur in the cardiovascular, ocular, and skeletal systems.  
The morbidity and mortality associated with the clinical presentation of MFS highlight the 
importance of early diagnosis and management3.  By far, the characteristics found within the 
cardiovascular system are the primary source of morbidity and early mortality and include 
dilatation of the aorta which can progress to aortic dissection/rupture, mitral valve prolapse 
with/without regurgitation, tricuspid valve prolapse, and enlargement of the proximal pulmonary 
artery3.  The hallmark feature within the ocular system is ectopia lentis, dislocation of the lens of 
the eye, and it is observed in approximately 60% of affected individuals3.  Of increasing concern 
and morbidity, patients with this syndrome are at increased risk for retinal detachment, 
glaucoma, and early cataract formation3.  Within the skeletal system, patients with MFS are 
characterized as having excessive linear growth of long bones and joint laxity3.  Excessive linear 
growth is demonstrated as an increased arm span to height ratio, the appearance of the 
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extremities being disproportionately long for the size of the trunk, and patients being abnormally 
tall for their age3.  Other skeletal features are observed in the craniofacial region and include a 
long and narrow face, downward slanting of the palpebral fissures, malar hypoplasia, and a 
retruded chin (retrognathia); intraorally, a highly-arched palate and dental crowding have been 
described3.  While features of MFS are present in other organ systems, the highly diagnostic and 
discriminating features are found within the cardiovascular, skeletal, and ocular systems.   
Etiology of MFS 
MFS is caused by a mutation in the gene coding for the protein fibrillin-1 (FBN1) 
resulting in reduced amounts of functional FBN13, 4.  Fibrillin-1 binds to other proteins to form 
microfibrils which are one of the fibers that provide flexibility and strength to connective tissue4.  
Microfibrils also store growth factors responsible for controlling growth and repair of tissues and 
organs throughout the body4.  Decreased amounts of functional FBN1 lead to a decreased 
formation of microfibrils, resulting in the release of excess growth factors, a decrease in tissue 
elasticity, tissue overgrowth, and tissue instability4.  The sequela of these events give rise to the 
clinical presentation of MFS, as the structural integrity of connective tissue is compromised2. 
MFS is an autosomal dominant disorder with 75% of new cases being the direct result of 
inheritance from a parent, and approximately 25% of new cases result from a new mutation3, 4.   
Epidemiology 
MFS is estimated to have a prevalence of 1-2:10,0000.  There is no predisposition based 
on ethnicity, race, or gender3, 5. 
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Diagnostic Criteria for Marfan Syndrome 
The diagnosis of MFS is a clinical diagnosis made by the observation of cardinal features 
in various organ systems, the presence of a family history of MFS, and/or genetic testing for a 
mutation of the FBN1 gene or other genes.  The most recent and revised diagnostic criteria, The 
Revised Ghent Nosology for the Marfan Syndrome, were published in 2010 by Loeys et al.6. The 
need for revision from the previous criteria7 arose from the observation more emphasis needed to 
be placed on hallmark features of MFS in the cardiovascular and ocular systems, and more 
consideration needed to be given to alternative diagnoses6.  The alternative diagnoses have 
clinical features that overlap with MFS but may also include features with a higher morbidity 
and/or mortality than MFS6.  In the revised criteria, more weight is given to two distinct features 
of MFS, aortic root aneurysm/dissection and ectopia lentis6.  Diagnostic criteria exist for other 
organ systems, as discussed below, but the diagnostic finding of both aortic root 
enlargement/dissection and ectopia lentis confers the diagnosis of MFS in the absence of 
discriminating features for other syndromes6.  While this is not the only pathway for being 
diagnosed, it highlights an important change to the diagnostic criteria.  The other pathways are 
outlined below, and include clinical findings in other organ systems, a family history of MFS and 
a positive mutation in the FBN1 gene6.  Additionally, there are features that are commonly 
observed in MFS that do not independently discriminate for MFS6.  If these features exist in 
combination, the diagnosis of systemic involvement for MFS is given; if there is systemic 
involvement and another hallmark feature, the diagnosis of MFS can be inferred6.     
Summary of the Diagnostic Algorithm for MFS below6: 
In the absence of a family history of MFS, a patient can be diagnosed with MFS if the 
patient has: 
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 Aortic diameter Z≥2 or dissection and ectopia lentis 
 Aortic diameter Z≥2 or dissection and mutation of FBN1 
 Aortic diameter Z≥2 or dissection and a systemic score ≥7 
 Ectopia lentis, mutation of FBN1, and known aortic dilatation (Z≤2) 
In the presence of a family history of MFS, a patient can be diagnosed with MFS if the 
patient has: 
 Ectopia lentis 
 Systemic score ≥7 
 Aortic diameter z≥2 or dissection if ≥20 years old  
 Aortic diameter z≥3 or dissection if ≤20 years old 
Aortic root enlargement/dilatation is defined for MFS as having an aortic root diameter 
measurement, at the level of the sinuses of Valsalva, with a Z-score (Z) ≥2 when 
standardized for age and body size6.  There are caveats to the above diagnostic criteria to 
rule out other syndromes.  See the revised criteria for these caveats6. 
The systemic score is calculated by summation of points, and a score ≥7 denotes systemic 
involvement: 
 Wrist and thumb sign—3 points (wrist or thumb sign 1 point) 
 Pectus carinatum—2  points (pectus excavatum or chest asymmetry 1 point) 
 Hindfoot deformity—2 points (plain pes planus 1 point) 
 Pneumothorax—2  points 
 Dural ectasia—2 points 
 Protrusio acetabuli—2 points 
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 Reduced upper segment:lower segment ratio and increased arm:height ratio and 
no severe scoliosis—1 point 
 Scoliosis or thoracolumbar kyphosis—1 point 
 Facial features (must have 3/5): dolichocephaly, enophthalmos, downslanting 
palpebral fissures, malar hypoplasia, retrognathia—1 point 
 Skin striae—1 point 
 Myopia > 3 diopters—1 point 
 Mitral valve prolapse—1 point 
As can be seen from the diagnostic criteria, emphasis is placed on those clinical features 
that carry the highest morbidity and mortality.  All skeletal features fall under systemic 
involvement even though they are some of the most striking physical features.  However, they 
don’t yield high diagnostic value independently.  Craniofacial features, the focus of this research, 
are included in the diagnostic criteria, but only reach diagnostic significance when multiple facial 
features are observed in combination.   
Challenges to Diagnosis   
As previously discussed, the diagnosis of MFS is primarily a clinical diagnosis and relies 
on the ability of a clinician to observe/identify features specific to the syndrome.  Diagnosis can 
by highly elusive due to the high degree of variability in clinical presentation, the age-dependent 
nature of some manifestations, and the host of differential diagnoses that exist3, 6, 8.   
Summers et al. described challenges encountered in diagnosing MFS within families 
presenting to the Marfan Clinic at Prince Charles Hospital in Brisbane, Australia9.  At the time of 
publication, the guidelines set forth by De Paepe et al.7 in 1996 were being used for the diagnosis 
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of MFS.  As an example, a family in this study had several members who were known carriers of 
a FBN1 mutation9.  Some had been diagnosed with ectopia lentis and some children within the 
family required surgical repair of mitral valve prolapse9.  These clinical findings would give 
clinical suspicion for a possible diagnosis of MFS9.  However, expressivity was found to be 
different within the family and there was inability to predict who would be more severely 
affected solely on the basis of a known FBN1 mutation9.  This finding is confirmed by Judge and 
others who noted that even when members of a family share the same mutation, phenotypic 
variation is prominent5, 8.  A different family in the Summers’ study demonstrated an occurrence 
of a de novo mutation in the FBN1 gene in a male child resulting in MFS9.  The sibling of this 
proband had musculoskeletal features consistent with MFS, but the features alone did not qualify 
him for a positive diagnosis of MFS9.  Genetic testing identified the de novo mutation in the 
proband and confirmed the absence of the mutation in the proband’s parents and sibling9.  
Identification of the mutation as being spontaneous rather than inherited provided reassurance 
the sibling of the proband likely did not have MFS9.   
Not only does there exist phenotypic variability of MFS within families, but there is also 
variability between ethnicities.  Franken and colleagues completed a retrospective review of 
Asian and Caucasian patients diagnosed with MFS10.  They found significant differences of 
clinical features in the cardiovascular, skeletal, and ocular systems between Asian and Caucasian 
patients10.  With regard to the cardiovascular system, Asian patients were more severely affected 
as demonstrated by a higher z-score for aortic diameter, increasing the likelihood for an adverse 
cardiac event10.  One explanation offered for this was under-diagnosis of MFS in Asian patients 
attributed to limited access to genetic testing; this results in a delay in management/treatment10.  
As pointed out in their article, MFS is a progressive disease and periodic monitoring is required 
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to allow for timely surgical intervention to slow the progression of cardiovascular defects10.  If a 
patient with MFS does not exhibit enough physical features to be diagnosed in the absence of 
genetic testing, the abnormalities associated with the syndrome can progress undetected until the 
abnormality reaches clinical significance10.  Within the skeletal system, the wrist/ thumb sign 
and arm span/height ratio >1.05 were more prevalent in the Asian patients10.  However, in the 
ocular system, ectopia lentis was more common in Caucasian patients10.  This research not only 
demonstrated the phenotypic variability that exists between ethnicities, it also highlighted the 
importance of assessing the applicability of the diagnostic criteria to patients of different 
ethnicities. 
 Diagnostic Criteria in Clinical Practice  
Researchers have evaluated the application of the diagnostic criteria for MFS to 
populations with and without MFS to determine how well the criteria discriminates between 
affected and non-affected individuals.  This is important as to lessen the incidences of false 
positives and false negatives in the diagnosis of MFS.   
Sponsellar and colleagues investigated ways in which patients were recognized as 
needing a referral for evaluation of MFS and the prevalence of current diagnostic features of in a 
population of subjects with and without MFS11.  They examined a population of patients 
attending care at a pediatric orthopedics clinic and a pediatric sports medicine clinic11.  The 
population consisted of patients with a confirmed diagnosis of MFS (n=183) and those without 
MFS (n=1257)11.  They examined the prevalence of physical, mostly skeletal, diagnostic features 
for MFS in both cases and controls11.  Overall, the physical diagnostic features were more 
prevalent in the MFS group, but > 30% of the control population had at least one of the described 
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physical features of MFS11.  When evaluating sensitivity and specificity of physical features, 
craniofacial features were the most sensitive for MFS and when combined with the thumb and 
wrist sign, the most specific11.  This demonstrates singular physical features of MFS are 
relatively prevalent within the general population, but that observed in isolation do not infer a 
diagnosis of MFS.  However, when multiple physical features are observed in combination, the 
suspicion for MFS increases.  Included in their research was identifying the individual 
responsible for initial suspicion for MFS resulting in referral for evaluation.  In 26% of cases it 
was a pediatrician, a family member in 21%, ophthalmologist in 14%, family practitioner in 
8.4%, orthopedist in 7.7%, and another contact (undefined) in 23% 11.  As can be seen from these 
findings, it is prudent practitioners from different specialties be knowledgeable about MFS.   
Ting and colleagues investigated the diagnostic value of facial features in MFS to 
determine if commonly observed facial features could potentially be used as an early screening 
tool for MFS12.  They evaluated specific facial features (dolichocephaly, enophthalmos, down-
slanting palpebral fissures, malar hypoplasia, and retrognathia) in a group of patients with a 
confirmed diagnosis of MFS (n=76) and a group of age- and sex-matched controls (n=76)12.  
Each subject was assessed using frontal and lateral photographs12.  Three physicians, with 
extensive experience evaluating patients with MFS, viewed the photographs to determine if the 
facial features were present or absent and recorded whether or not the facial features triggered a 
suspicion for MFS12.  All of the facial features were significantly more prevalent in the MFS 
group compared to the control group12.  Overall, the facial features had a sensitivity of 53.9% 
and a specificity of 91.2%12.  The physicians were able to discriminate between subjects with 
MFS and controls with an accuracy of 72.6% by evaluating facial features in the frontal and 
lateral photographs12.  Their findings also revealed the presence of more than one facial feature 
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increased the odds of correctly identifying a patient with MFS12.  They concluded the facial 
features were more specific than sensitive and could be used as a tool to prioritize patients for 
referral for evaluation for MFS; however, they should not be relied upon as the sole metric for 
initial screening12.   
Diagnosis and Phenotype in Children 
As mentioned, the diagnosis of MFS can be challenging due to the age-dependent nature 
of some physical features; these features do not manifest or become distinct for MFS until after 
significant growth has occurred.  Research emphasis has been placed on ways to diagnose MFS 
sooner in life as this leads to earlier management and treatment.  Several researchers have 
studied MFS in children/adolescents specifically to understand the phenotypic presentation in 
this population.   
Lipscomb and colleagues evaluated 40 subjects with MFS less than 16 years of age8.  Of 
the 40 evaluated, 10 were index cases with no prior family history of MFS8.  This percentage of 
index cases, 25%, is in agreement with the global description of all patients, children and adults, 
with MFS8.  For the index cases, the average age at diagnosis was 11.4±3.95 years and for non-
index cases, 7.31±5.23 years8.  In regard to craniofacial features of MFS, 36 of 40 subjects were 
described as having a highly-arched palate and 33 of 40 were noted to have mid-face hypoplasia, 
micrognathia, and down-sloping palpebral fissures8.  When evaluating the cardiovascular system, 
aortic root dilatation was observed in 17 patients (42.5%) but none of the subjects had 
experienced an aortic dissection8.  This is less than the prevalence of aortic dilatation reported by 
Mueller et al. in their examination of pediatric patients with MFS13.  They found that 56% of 
their population had aortic dilatation but none had experienced an aortic dissection13.  It is 
recommended patients with MFS have annual echocardiographic examinations to detect and 
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monitor aortic root dilatation; a delay in detection can potentially lead to adverse clinical 
outcomes8.  As can be seen, index cases tended to be diagnosed later in childhood resulting in 
missed years of echocardiographic examination and delayed prophylactic intervention to manage 
aortic root dilatation.  It highlights the need for diagnostic criteria to help identify index cases 
earlier in life.   
Stheneur and colleagues evaluated children referred to a Marfan Clinic in France either 
due to the suspicion of MFS or a family history of MFS14.  They sought to further document the 
phenotypic evolution of MFS with age in children.  In adults, the phenotype has been well-
described and documented, but because of the phenotypic variability and incomplete phenotypic 
display in children, it can be difficult to diagnose MFS in children14.  It is more likely those 
children with severe phenotypic expression are identified earlier, while those with variable or 
less phenotypic expression go undetected, especially in the absence of genetic testing14.  Their 
study population consisted of children under the age of 18 with MFS (n=259), as confirmed 
through meeting the Ghent I criteria and having a FBN-1 mutation, and those without MFS 
(n=474)14.  Within each of the groups, MFS and non-MFS, the subjects were further stratified by 
age (0-6years; 7-9years; 10-14years; and 15-17years)14.  They evaluated the presence of skeletal 
features, cardiovascular features and ocular features, diagnostic for MFS, in both groups14.  For 
all age strata, children with MFS were significantly taller than the non-MFS children, and that a 
height >3.3SD above the mean carried a positive predictive value for MFS of 72%14.  For the 
MFS group, an aortic root diameter >3SD from the mean was present in greater than 60%; 
whereas for the non-MFS, it was present in <10%14.  When examining probands and non-
probands within the MFS group, probands were less represented in the younger age strata and 
were more severely affected than non-probands when evaluating aortic diameter and the 
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presence of ectopia lentis14.  The two most discriminating features leading to a diagnosis of MFS 
were aortic diameter >3SD above the mean and presence of ectopia lentis, both of which were 
given more weight in the most recent diagnostic criteria for MFS14.  The findings in this study 
are in agreement with those of the Lipscomb study which showed probands are diagnosed later 
in life; they also demonstrated probands were more severely affected clinically.   
Benefits of Early Diagnosis 
The morbidity associated with MFS underlines the importance of early diagnosis to 
improve prognosis and delay mortality.  The features with the gravest clinical outcomes occur in 
the cardiovascular system and require early intervention to allow for favorable outcomes.  Willis 
and colleagues evaluated outcomes in patients with MFS diagnosed in childhood (diagnosis 
before 18 years of age) and those diagnosed in adulthood (diagnosis after 18 years of age)15.  In 
their study, 27 of 66 patients with MFS were diagnosed in childhood and 39 of 66 in adulthood 
15.  Those diagnosed in adulthood had significantly greater cardiac morbidity as measured by 
median aortic root diameter, need for aortic surgery, aortic insufficiency, and repeat aortic 
surgery 15.  They were also more likely to require aortic root replacement on an urgent basis due 
to an associated aortic dissection or severe aortic insufficiency 15.  This highlights the importance 
of early diagnosis as those “who remain undiagnosed until adulthood have well-established 
cardiovascular pathology and a suboptimal clinical outcome 15.”  As previously discussed, earlier 
diagnosis allows for annual echocardiographic examination to monitor aortic root diameter 
which leads to timely intervention rather than emergent intervention which may limit the 
treatment options available.   
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Consequences of Misdiagnosis 
There are several consequences of misdiagnosis of MFS for a patient who indeed does 
not have MFS.  Included are inappropriate/improper surveillance and or treatment that can be 
costly, discrimination by employers, or discrimination and/or difficulty with obtaining 
insurance9.  Alternatively, a missed diagnosis of MFS infers more severe consequences as 
premature death can result from an aortic dissection.   
Management of Marfan Syndrome 
The multi-system nature of MFS dictates a multidisciplinary approach to comprehensive 
management.  For most patients, this requires a team including a cardiologist, cardiothoracic 
surgeon, ophthalmologist, orthopedist, and geneticist3.  Annually, these patients are monitored 
with an echocardiogram to monitor aortic dilatation and an ophthalmologic exam to assess for 
ectopia lentis, cataracts, glaucoma, or retinal detachment3.   
When medical professionals encounter these patients outside of the specialties outlined 
above, it is common for patients with MFS to present with eyeglasses for correction of myopia 3, 
6.  Aortic dilatation is usually managed by medications to reduce the hemodynamic stress placed 
on the aortic wall such as beta blockers 3, 6.  For dental professionals, these patients may require 
antibiotic prophylaxis prior to invasive dental treatment in the presence of mitral valve or aortic 
valve regurgitation3.   
A diagnosis of MFS infers lifestyle modifications to prevent or reduce associated 
morbidities and/or mortality.  Some of these changes or limitations include avoiding contact 
sports, competitive sports, exercise to exhaustion, and isometric exercise3.  However, patients 
can and are encouraged to participate in aerobic activities in moderation3, 6.  Additionally, 
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patients are cautioned to avoid substances that stimulate the cardiovascular system such as 
caffeine or decongestants3.   
Although MFS is considered a rare disease, it is likely a medical professional will 
encounter a patient with MFS during his/her professional career.  Awareness of MFS and its 
clinical presentation is of importance as it may have implications for the medical treatment being 
provided. In addition, the findings of medical practitioners from different specialties may be 
instrumental in enhancing the diagnostic criteria for MFS, increasing awareness, and developing 
new research avenues.   
Craniofacial Characterization of Marfan Syndrome 
Research continues to focus on isolating and describing clinical/physical features that 
discriminate for MFS.  One such area of research devoted to this is qualitatively and 
quantitatively describing craniofacial and dental features of patients with MFS.   
De Coster and colleagues evaluated the craniofacial structure of patients with MFS using 
cephalometric measurements to quantitatively assess facial features that previously had only 
been described qualitatively16.  Of interest, was characterization of the relative position of the 
maxilla and mandible to the cranial base by evaluating the SNA angle and SNB angle; also they 
wanted to evaluate the relative position of the maxilla to the mandible through the angular 
measurement of ANB16.  The normative values for these measurements had been previously 
described by Steiner17.  The normal angular measurement for SNA is 82° indicating a normally 
positioned maxilla relative to the cranial base17.  A measurement greater than 82° is indicative of 
a prognathic maxilla and a measurement less than 82° of a retrognathic maxilla17.  The normal 
angular measurement for SNB is 80° indicating a normally positioned mandible to the cranial 
14 
base17.  A measurement greater than 80° is indicative of a prognathic mandible and less than 80° 
indicative of a retrognathic mandible17.  For the ANB measurement, a normal Class I relationship 
between the maxilla and mandible exists when the angular measurement is between 2°-4°17.  A 
measurement greater than 4° is indicative of a Class II jaw relationship and less than 2° of a 
Class III jaw relationship17. They also evaluated vertical skeletal relationships by assessing the S-
N/Go-Gn angle; 32°=normal; greater than 32°=long face; and less than 32°=short face17.  Of 
their population of 26 subjects with MFS, 84% were maxillary retrognathic, 88% were 
mandibular retrognathic, and 81% were both maxillary and mandibular retrognathic16.  With 
respect to ANB, 44% had a normal ANB measurement while 48% had a measurement indicative 
of a Class II jaw relationship16.  When evaluating the vertical skeletal relationship, 72% of the 
subjects fell into the long face category16.  These findings are in agreement with the skeletal 
diagnostic features of MFS previously described which include dolichocephaly (long-face) and 
mandibular retrognathia.  Their research was novel because is quantitatively described 
craniofacial features and provided a method and benchmark for comparison for future research.     
Staufenbiel and colleagues investigated the periodontal health of patients with MFS18.  
Considering that the periodontal ligament is comprised of elastic fibers and that MFS is a 
connective tissue disorder, they sought to find out if patients with MFS are more susceptible to 
periodontal disease18.  The sample included 51 patients with MFS, average age of 40.2±15.3 
years, and 31 controls, average age 40.29±13.9 years18.  The periodontal examination of each 
subject recorded probing pocket depth, gingival recession, clinical attachment level, and bleeding 
on probing assessed at six sites per tooth18.  They found no significant difference between the 
MFS subjects and the control subjects in any of the periodontal parameters evaluated18.  As a 
part of the study, the subjects with MFS completed a questionnaire inquiring about 
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temporomandibular disorders and previous orthodontic treatment18.  Disorders of the 
temporomandibular joint were reported by 39.2% of the MFS subjects and 62% had previous 
orthodontic treatment18.  It is expected that all patients with MFS would be encouraged to receive 
routine dental care with a primary dentist, but it is also likely these patients will be evaluated 
and/or treated by dental specialists for either temporomandibular disorders or for orthodontic 
treatment.  As such, dental professionals may be in a unique position to identify patients with 
MFS and aid in further research on craniofacial and dental characterization of patients with MFS.     
Craniofacial Characterization of other Syndromes 
There are several medical syndromes that include craniofacial anomalies.  The facial 
anomalies associated with each syndrome can be highly discriminating for the syndrome and as 
such, are used in diagnosis.  Leslie Farkas recognized this, and sought to develop a method for 
evaluating and quantifying craniofacial characteristics of syndromes with distinct facial features 
such as Down’s Syndrome and Apert’s Syndrome19, 20.  He found the facial features observed 
were described qualitatively in the literature but without quantification and/or comparison to 
controls/normative data19, 20.   
Farkas’ previous research evaluating the facial anatomy of normal subjects, using 
anthropometric measurements, provided the normative data needed as a control population21.  
His population for establishing the norms consisted of normal, healthy, North American children 
in Canada; subjects were recruited from schools and summer camps21.  He sought to achieve a 
sample population of male and female subjects between the ages of 0-25 years21.  He made 
anthropometric measurements on the head and face of each subject; from this data, a mean and 
SD for each measurement, by age group and sex, were calculated to establish the norm for the 
anthropometric measurement21.     
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His quantitative investigation of the facial anatomy of patients with Down’s Syndrome 
included making select craniofacial anthropometric measurements on a test population of 
subjects with Down’s Syndrome19.  He selected the measurements based on previous research 
that identified specific facial features commonly observed in patients with Down’s Syndrome22.  
The measurements from the subjects with Down’s Syndrome were then compared to normative 
data by calculating a z-score for each measurement19.  He categorized the measurements based 
on z-score as listed below19: 
 z score±1: optimal facial measurement 
 z score <-1 but >-2 or >1 but <2: normal facial measurement 
 z score <-2 or >2: subnormal or supernormal facial measurement 
 z score <-3 or >3: severe facial abnormality 
The results from this study provided quantitative evidence for qualitatively described 
differences in craniofacial morphology of patients with Down’s Syndrome.  This method of 
research provided a framework for future research in quantitatively describing facial features of 
syndromes with known craniofacial anomalies19.   
Conclusion 
While research continues to evolve in regard to treatment strategies for MFS to improve 
quality of life and prognosis, these findings are most beneficial when implemented early.  Early 
diagnosis is dependent upon careful observation and identification of the clinical features 
associated with this syndrome.  The challenges to observing the clinical features in younger 
populations have been outlined and a focus in research has been to discover, or further define, 
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clinical features of MFS in the child/adolescent population.  As such, this research project aims 
to quantitatively and qualitatively describe craniofacial features in child/adolescent patients with 
MFS by, 1) making select craniofacial anthropometric measurements on each subject and 
comparing these measurements to normative data and 2) evaluating clinical photographs of 
subjects with MFS to identify discriminating features.   
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CRANIOFACIAL CHARACTERIZATION OF MARFAN SYNDROME 
 
Introduction 
Marfan Syndrome (MFS) is a life-threatening connective tissue disorder characterized by 
multi-system organ involvement with cardinal features occurring in the cardiovascular, ocular, 
and skeletal systems1.  It is caused by a mutation in the gene coding for the protein fibrillin-1 
(FBN1)2.  The morbidity and mortality associated with the clinical presentation of MFS highlight 
the importance of early diagnosis and management.  The characteristics found within the 
cardiovascular system (aortic dilatation and/or aortic dissection) are the primary source of 
morbidity and early mortality1, and it has been noted that undiagnosed adult patients have well-
established cardiovascular pathology and suboptimal clinical outcomes3.  Within the ocular 
system, the hallmark feature is ectopia lentis (dislocation of the lens of the eye), a condition seen 
in approximately 60% of patients1.  While the features in the skeletal system are not a major 
source of morbidity/mortality and do not account for sudden or premature death, they are 
fundamental in diagnosis4.  Skeletal features are the most striking physical features of MFS and 
may lead to a suspicion for this syndrome in undiagnosed patients.  These features include 
excessive linear growth of long bones, increased arm span to height ratio, and distinct 
craniofacial features (dolichocephaly, malar hypoplasia, enophthalmos, retrognathia, and down-
slanting palpebral fissures)1.  While features of MFS occur in other organ systems, the 
observation of discriminating features in these three systems often leads to the diagnosis of MFS.     
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 The diagnosis of MFS is a clinical diagnosis, and the diagnostic criteria are outlined in 
The Revised Ghent Nosology for the Marfan Syndrome published by Loeys et al. in 2010 (see 
Appendix 1).  The criteria set forth objective clinical requirements that must be observed to infer 
the diagnosis of MFS; consideration is given to clinical findings in various organ systems, a 
family history of MFS, and a positive mutation of the FBN1 gene 5.   
 Prior research has highlighted the value of early diagnosis as a prerequisite for improved 
clinical outcomes 3; however, diagnosis can be highly elusive due the high degree of variability 
in clinical presentation and the age-dependent nature of some features 1, 5, 6.  Additionally, the 
hallmark features, aortic dilatation/aneurysm and ectopia lentis, require more advanced 
diagnostic tests than are routinely prescribed for the general population7.  This underscores the 
need for a method to objectively assess other readily observable features as a screening tool for 
MFS.  Studies have evaluated the application of the diagnostic criteria in populations consisting 
of MFS subjects and non-MFS subjects to determine how well the criteria discriminate between 
affected and non-affected individuals; these studies found that facial features, as outlined in the 
MFS diagnostic criteria, are valuable in diagnosis.  Ting and colleagues utilized frontal and 
lateral photographs to evaluate facial features of patients with a confirmed diagnosis of MFS and 
age- and sex-matched controls8.  Three physicians with extensive experience treating patients 
with MFS evaluated all photographs for the presence of the five diagnostic craniofacial features8.  
The physicians were able to discriminate between subjects and controls with an accuracy of 
72.6% solely on the basis of assessing facial features8.  Similarly, Sponseller and colleagues 
evaluated the diagnostic sensitivity and accuracy of the presence of not only craniofacial 
features, but also other skeletal features, finding that craniofacial features were the most sensitive 
discriminator between individuals with and without MFS 7.  Also, the combination of 
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craniofacial features with a positive thumb sign provided the highest diagnostic accuracy 7.  Of 
equal importance, was their finding that 19% of MFS patients had zero or one skeletal feature 
and that in very young patients, it may take time for the full phenotype to evolve 7.  The authors 
concluded that further studies are needed to objectively define and describe craniofacial features 
as currently, they are only subjectively defined 7.  In summary, current literature demonstrates 
the pivotal role craniofacial features may play in the diagnosis of MFS, especially in the absence 
of a family history of MFS, genetic testing, or other discriminating features. 
 Few studies have attempted to quantify the facial features described for MFS in the Ghent 
Nosology as most have been qualitative studies.  The quantitative studies that have been 
conducted have used lateral cephalometric radiographs to compare craniofacial findings from 
MFS patients to control subjects 9, 10.  We report here the first anthropometric study of patients 
affected with MFS in order to:  1) quantify craniofacial features in a cohort of child, adolescent, 
and young adult patients with a confirmed diagnosis of MFS and compare them to a control 
population, 2) qualitatively examine subjects for the presence of diagnostic facial features, 3) 
document occlusal relationships, and 4) collect relevant demographic and biometric information.   
Methods: 
This cross-sectional study was approved by the Institutional Review Board at the 
University of North Carolina at Chapel Hill.   
Sample: 
Subjects were recruited during the Marfan Foundation Annual Conference in Chicago, IL 
in 2015 and in Rochester, MN in 2016.  The study population included twenty (N=20) 
individuals with a confirmed diagnosis of MFS.  The mean age of the study population was 
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10.7±6.0years (age range 4-25 years).  The subjects were primarily female (60%) and white 
(70%) (see Table 1 for complete demographic data).     
Inclusion Criteria:  
Confirmed diagnosis of MFS and subject age between 4-25 years.   
Procedures: 
Craniofacial Assessment: 
Twelve craniofacial anthropometric measurements (see Table 2 for craniofacial 
measurements) were obtained on each subject using spreading and sliding calipers as described 
by Farkas 11.   The test measurements were compared to age- and sex-matched controls from 
previously published normative data by calculating a z-score for each measurement11.  Z-scores 
were categorized using a classification system describing facial dimensions that was developed 
by Farkas and colleagues12.   
Categorization of z-scores was as follows12:   
 z-score±1: optimal facial measurement 
 z-score: <-1 but >-2 or >1 but <2: normal facial measurement 
 z-score: <-2 or >2: subnormal or supernormal facial measurement 
 z-score: <-3 or >3: severe facial abnormality 
Photographs including a lateral, frontal in repose, and frontal smiling were obtained to 
document and qualitatively describe facial features.  Each subject was assessed for the 
presence/absence of the five craniofacial diagnostic criteria for MFS: dolichocephaly, malar 
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hypoplasia, enophthalmos, retrognathia, and down-slanting palpebral fissures 5.  The definition 
of these facial features, as outlined by the National Human Genome Research Institute, was used 
as a rubric to complete this part of our analysis 13, 14.  Two examiners evaluated all photographs 
independently and recorded his/her clinical judgment of the presence/absence of each facial 
feature.  When disagreement occurred between the examiners, a consensus diagnosis was 
reached after discussion.    
Intraoral Examination: 
A clinical exam was completed to document occlusal relationships.  For those subjects 
with erupted first permanent molars, the Angle Classification System, Class I, Class II, and Class 
III dental malocclusion, was used to document molar and canine relationships15.  For those in the 
primary dentition, molar classification was recorded as mesial step, distal step, or flush terminal 
plane 15. 
Questionnaire:  
 Each subject or subject’s guardian completed a questionnaire to obtain biometric and 
demographic information.   
Statistical Analysis:   
Statistical analysis were undertaken using Microsoft Excel 2013 (version 
15.0.4885.1000) and Statistical Analysis System (SAS) version 9.3 (Cary, NC).  Individual z-
scores were calculated in Microsoft Excel for each test measurement using the mean 
measurement and standard deviation of age- and sex-matched controls11.   
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The z-scores were grouped as described by Farkas12.  In SAS, a Fisher’s exact test, using 
a level of significance of p=.05, was completed for each craniofacial anthropometric 
measurement to compare the observed frequency of z-score distribution to an expected frequency 
of z-score distribution of a normal population (see Figure 1).  
Data was stratified by family history (proband vs non-proband), cardiovascular diagnosis 
(cardiovascular anomaly vs no cardiovascular anomaly) and by age (5-9; 10-14; 15-18; and 19-
25).  A Fisher’s exact test, (p=.05), was completed to compare frequency of z-score distribution 
between the groups.  For these groups, we evaluated only the frequency of z-score distribution 
for z-scores outside of the normal range (z<-2 or z>2) (see Figure 2).   
The remaining data from the clinical exam, photographic exam and questionnaire are 
presented as percentages.   
Results: 
Demographic and Biometric Results: 
Our analysis of the demographic and biometric data revealed fifty percent of subjects had 
no family history of MFS (probands) and fifty percent had a family history of MFS (non-
probands).  The average age at diagnosis for the entire sample was 5.9±4.6 years.  For probands, 
the average age at diagnosis was 6.7±5.1 years and non-probands, 5.1±4.0 years.  The average 
age at diagnosis was not statistically different between probands and non-probands (p=0.47).   
Forty percent of subjects reported one or more cardiovascular anomalies (see Figure 3), 
and sixty percent reported no cardiovascular anomalies.  The most prevalent cardiovascular 
anomaly was aortic dilatation (35%).   
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Eighty percent of subjects reported one or more ocular anomalies (see Figure 4), and 
twenty percent reported no ocular anomalies.  The most prevalent ocular anomaly was ectopia 
lentis (35%).     
Thirty-five percent of subjects reported current or a past history of orthodontic treatment, 
while 55% reported no history of orthodontic treatment.  Two subjects/guardians did not provide 
an answer to this question.     
Intraoral Examination Results: 
Fifty percent of subjects had a Class I molar relationship, 40% Class II, and 5% Class III.   
Assessment of Lateral and Frontal Photographs: 
All facial features described in the diagnostic criteria were observed in our subjects (see 
Figure 5).  The most prevalent facial features observed were retrognathia (54%) and down-
slanting palpebral fissures (62%).   
Craniofacial Anthropometric Measurements: 
For all 12 craniofacial anthropometric measurements, the frequency of z-score 
distribution for our MFS sample was significantly different from the distribution expected in a 
normal population, p=.05 (see Table 3).  Our subjects tended to be under-represented in the 
optimal/normal categories and over-represented in the subnormal, supernormal, and abnormal 
categories.   
For 9 of the 12 craniofacial measurements, the majority of subjects (≥65%) fell within the 
normal range for facial dimension with a z-score of ±2.  For 3 of the 12 measurements, biocular 
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width, facial width, and width of the nose, the majority of subjects fell outside the normal range 
for facial dimension (see Figures 6-17).     
Frequency of z-score Distribution by Groups 
 There was no statistically significant difference in frequency of z-score distribution for 
craniofacial measurements for probands vs. non-probands, those with or without a cardiovascular 
anomaly, or by age (p=.05).   
Discussion: 
In this cross-sectional study, we evaluated biometric and demographic markers, occlusal 
relationships and craniofacial morphology in child, adolescent and young adult patients with 
MFS.  We sought to discover if quantifiable differences in facial morphology existed in our 
subjects when compared to a control population, and to determine if biometric markers could be 
correlated to facial morphology.  Our aim was to enhance the current body of literature related to 
the diagnostic value of craniofacial findings in patients with MFS by quantifying differences in 
facial features which may aid in earlier recognition and diagnosis.   
In regard to biometric data collected, many of our findings agree with previously 
published research.  For age at diagnosis, though not statistically different, we found that 
probands tended to be diagnosed later in life than non-probands.  Lipscomb et al. and of 
Stheneur et al. had similar findings 6, 16.  Lipscomb and colleagues evaluated pediatric patients 
with MFS (N=40) and found the average age at diagnosis for probands was 11.4±3.95 and for 
non-probands, 7.31±5.23 years 6.  The morbidity and mortality associated with MFS emphasize 
the importance of early diagnosis and intervention as the main barrier to optimal outcomes is 
lack of timely diagnosis3.  Those with a family history of MFS, non-probands, are early on the 
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radar to be evaluated for MFS, as it is known this syndrome is inherited in an autosomal 
dominant pattern.  Whereas for probands, there must be a compelling clinical finding or adverse 
clinical event for a diagnostic evaluation for MFS to be pursued.  The recommended annual 
echocardiographic and ocular examination for patients with MFS or suspected MFS should be 
implemented as early as possible to assess for the presence/progression of aortic dilatation and 
ectopia lentis1.  This yearly surveillance is delayed in implementation for undiagnosed probands 
and has the potential to lead to adverse clinical outcomes.  There are several reported incidences 
of the diagnosis of MFS being made post-mortem in individuals who died suddenly as a direct 
result of cardiovascular complications related to MFS17, 18.  To avoid these types of outcomes, 
diagnostic strategies have to focus on identifying probands at an earlier age to allow for 
prophylactic medical intervention.           
When evaluating cardiovascular morbidity associated with MFS, 40% of our subjects 
reported at least one cardiovascular anomaly and some reported multiple anomalies.  The 
cardiovascular anomaly that carries significant diagnostic weight for MFS is aortic root 
dilatation; however, for diagnostic significance, the aortic dilatation must meet a threshold (z-
score) based on the patient’s age and body size 5.  We only evaluated for the presence of aortic 
dilatation and did not assess the degree of dilatation.  We found that 35% of subjects reported 
aortic dilatation which is less than that reported in previous studies by Lipscomb et al. and 
Mueller et al. who found that 42.5% and 56% of their pediatric MFS populations, respectively, 
had aortic dilatation6, 19.  Stheneur and colleagues evaluated pediatric patients with and without 
MFS and found that >60% of subjects with MFS had an aortic root diameter >3 SD from the 
mean (corrected for height and weight) compared to only 10% of subjects without MFS 16.  
When the most recent diagnostic criteria for MFS were published in 2010, increased emphasis 
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was placed on aortic dilatation as a hallmark feature as it is not observed frequently in the 
general population 5.  It has been noted that many manifestations of MFS are age-dependent 
which may explain the lower prevalence found in our younger study population 1, 5.  It is possible 
that aortic dilatation had not yet manifested in our subjects resulting in a lower reported 
prevalence.   
When evaluating ocular morbidity, 80% of subjects reported at least one ocular anomaly 
and some reported multiple anomalies.  The ocular anomaly that is highly specific for MFS is 
ectopia lentis and is reported to occur in 60% of patients with MFS 1, 16.  In our population, 35% 
of subjects reported ectopia lentis and 10% lens removal which is a treatment modality for severe 
cases of ectopia lentis 20.  Once again, our decreased prevalence could be due to our younger 
sample population and this condition not yet manifesting.         
In our questionnaire, we inquired about each subject’s history of orthodontic treatment.  
Thirty-five percent of subjects reported a prior history of orthodontic treatment.  While no 
clinical dental findings are included in the most recent diagnostic criteria for MFS, they were 
included in the previous diagnostic criteria published in 199621.  Several studies and case reports 
have reported on dental findings in patients with MFS focusing on palatal vault height, palatal 
width, and dental crowding 10, 22, 23.  Docimo et al. evaluated pediatric patients with MFS (N=32) 
and found that 56% of subjects had a crossbite (mono- or bilateral) and 69% had evidence of an 
ogival (high and arched) palate; they estimated the prevalence of crossbite in their MFS 
population was 2.5 to seven times more frequent than the normal population10.  We found 25% 
of our subjects reported maxillary expansion as a part of their orthodontic treatment.  It is 
unknown if maxillary expansion was prescribed due to a narrow palate and/or crossbite, but 
maxillary expansion is a treatment modality for these malocclusions.  Staufenbiel and colleagues 
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reported on the prevalence of orthodontic treatment among subjects with MFS and found that 
62% (N=51) had a previous history of orthodontic treatment.  Their study population was older 
(mean age 40.2± 15.4years) than our population which could account for the discrepancy in 
orthodontic treatment prevalence 24.  Orthodontic treatment is rarely indicated in the primary 
dentition and is not routinely recommended in the mixed dentition stage.  It is likely some 
subjects in our sample were not at a developmental stage to warrant orthodontic treatment at the 
time they were included in our study.   
In this report, we also evaluated occlusal relationships to determine if certain features 
were characteristic of MFS patients.  We found that 40% of our subjects had a Class II or mesial 
step molar occlusion.  Previous studies have reported on Class II molar relationships and excess 
overjet in patients with MFS 22, 25, 26.  However, these features are not highly discriminate for 
MFS and occur in the general population.  The recommended treatment to address this 
malocclusion would not differ significantly for patients with MFS when compared to the general 
orthodontic population.   
 Clinical photographs were taken on thirteen subjects and assessed for the facial features 
outlined in the most recent diagnostic criteria. Lateral photographs taken on six subjects were 
undiagnostic for assessment for dolichocephaly, and therefore, the assessment for the presence of 
dolichocephaly was completed on only 7 subjects.  We found that 43% of subjects presented 
with dolichocephaly which is slightly less than reported in a study by Docimo et al. who found 
that 47% of pediatric patients with MFS had dolichocephaly; their sample size (N=32) was much 
larger than ours10.  Retrognathia and down-slanting palpebral fissures were the two most 
prevalent facial features in our population being observed in 54% and 62% of our sample 
population respectively.  When compared to a previous study of pediatric MFS patients, the 
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presence of retrognathia was reported as 56%10.  Ting and colleagues evaluated facial features in 
an older population of MFS patients (N=76; mean age=18 years, age range 1-55 years), and 
found dolichocephaly in 60%8.  It could be speculated the decreased prevalence of facial features 
in pediatric populations exists because the subjects have not “grown into” these features 1, 6, 9.  A 
longitudinal assessment of facial features of pediatric MFS patients would allow for investigation 
to determine if facial features become more prevalent with age.   
 For 9 of the 12 craniofacial anthropometric measurements, the majority of subjects 
(≥65%) fell within the normal range (z-score ±2) for facial dimension.  When compared to age- 
and sex-matched controls, the facial features of our sample population did not vary significantly 
from the control mean.  De Paepe et al. noted the nature of the phenotype of MFS is a continuum 
that at the mild end of the spectrum, merges with the normal population21.  The historical 
literature for MFS reports that some musculoskeletal features are absent or less evident during 
growth, and diagnosis in children or teenagers can be difficult4 which likely accounts for our 
findings.  For three of the measurements, biocular width, facial width, and width of the nose, the 
majority of our subjects fell outside of the normal range.  For biocular width, our subjects had a 
super normal/abnormally wide biocular width.  Down-slanting palpebral fissures has been well 
documented in patients with MFS and is a part of the current diagnostic criteria 5.  Down-
slanting of the palpebral fissures appears as a downward drop of the lateral aspect of the eye 
fold; this results in a more pronounced elliptical shape of the eye which may account for this 
finding.  For facial width, our subjects had a subnormal/abnormally narrow facial width; malar 
hypoplasia is prevalent in MFS 5 and likely explains this finding.  When considering width of the 
nose, we found that 25% had a subnormal/abnormally narrow nose and 30% had a 
supernormal/abnormally wide nose.  A narrow width of the nose may follow an overall narrow 
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width of the face.  However, there have been not previous reports of increased nasal width in 
MFS patients.  The only explanation we can provide is normal variation that exists within a 
population.  We could not find any other studies that utilized craniofacial anthropometric 
measurements to assess facial features in MFS and therefore cannot compare our findings to 
other studies.   
 We evaluated frequency of z-score distribution for all craniofacial measurements between 
probands and non-probands, those with and without cardiovascular anomalies, and by age.  Our 
purpose in doing so was to determine if probands showed more deviation from the norm than 
non-probands which could have potentially led to a suspicion for MFS.  For cardiovascular 
anomalies, we aimed to determine if those who reported a cardiovascular anomaly were more 
severely affected globally in other organ systems such as the skeletal system.  By stratifying our 
sample by age, we sought to find out if craniofacial morphology became more abnormal as age 
increased.  For all of our analyses, we found there was no statistically significant difference in 
frequency of z-score distribution between the groups.  Studies have reported the phenotypic 
expression of MFS is unpredictable 27, 28 which possibly explains our finding of no difference 
between groups.  It has also been noted that phenotypic variation is prevalent in families with 
MFS carrying the same genetic mutation, and attempts to find genotype-phenotype correlations 
have been met with limited success16, 28-30.  While this may partly explain our findings, our small 
sample size is likely a contributing factor too; we simply may not have recruited enough subjects 
to detect differences.     
 Overall, our sample of child, adolescent and young adult patients with MFS demonstrated 
quantifiable differences in three craniofacial features when compared to age- and sex-matched 
controls.  However for nine of twelve measurements, the majority of subjects did not 
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demonstrate a quantifiable difference in craniofacial morphology.  This does not mean a 
difference does not exist, but that continued research with larger sample sizes needs to be 
pursued.  It is also likely that the use of published norms, with large standard deviations, was a 
less sensitive tool to detect meaningful differences.  We could not find any other studies that 
utilized our method of analysis to which our findings could have been compared, underscoring 
that this study represents the first time craniofacial features of MFS have been assessed with 
anthropometric analysis.   
Conclusions:  
1.)  Probands tended to be diagnosed later in life than non-probands.  
2.)  Aortic dilatation and ectopia lentis were present in our study population but not as 
prevalent as reported in previous studies.   
3.)  Retrognathia and down-slanting palpebral fissures were the two most prevalent 
diagnostic facial features in our study population. 
4.)  Our hypothesis of quantifiable, distinct craniofacial features for MFS was rejected for 9 
of 12 craniofacial measurements, as the majority of subjects fell within the normal range 
for facial morphology.  However it was accepted for 3 of the 12 measurements (binocular 
width, facial width, and width of the nose), as the majority of subjects fell outside the 
normal range.      
5.) There was no statistically significant difference in frequency of z-score distribution for 
craniofacial anthropometric measurements between probands vs. non-probands, subjects 
with or without a cardiovascular anomaly, or by age.   
Limitations: 
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 The age- and sex-matched controls were historical controls being established nearly 20-
30 years ago.  It is unknown if facial dimensions have evolved over time.  Also, the control 
sample consisted of only North American whites.  Our sample included Hispanic and Asian 
subjects and facial morphology may be different between races.   
 The craniofacial anthropometric measurements made on each subject require correct 
landmark identification and accuracy when making the measurements.  There could have been 
error introduced into the measurements due to incorrect landmark identification or due to 
inaccurate measurements.   
 The biometric data obtained using the questionnaire was not verified by referencing the 
subject’s medical chart.  This could have resulted in under- or over-reporting.   
Future Directions: 
Future directions for research on quantifying facial features for MFS include use of 3D 
photography and/or cone-beam computed tomography.  Both of these techniques allow for 
repeated measures to be made on test subjects, archiving of data, and require less time and 
cooperation for each subject.   
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Table 1.  Sample demographic data 
 N=20 
Males 8 (40%) 
Females 12 (60%) 
White 14 (70%) 
Hispanic 4 (20%) 
Asian 2 (10%) 
 
Table 2.   Craniofacial measurements 
Craniofacial Measurement Landmarks 
Morphological Height of Face N-Gn 
Physiognomical Height of Upper Face N-Sto 
Mandible Height Sto-Gn 
Lower Face Height  Sn-Gn 
Nose Height N-Sn 
Width of Nose Al-Al 
Biocular Width Ex-Ex 
Intercanthal Width En-En 
Width of Head Eu-Eu 
Width of Forehead Ft-Ft 
Width of Face Zy-Zy 
Width of Mandible  Go-Go 
 
Table 3:  p-values for frequency of z-score distribution MFS population vs. normal 
population 
Craniofacial Measurement p-value 
Morphological Height of Face .0103 
Physiognomical Height of Upper Face .0131 
Mandible Height .0011 
Lower Face Height  .0079 
Nose Height .0023 
Width of Nose <.0001 
Biocular Width <.0001 
Intercanthal Width <.0001 
Width of Head .0008 
Width of Forehead .0081 
Width of Face <.0001 
Width of Mandible  .0091 
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Figure 1. Frequency of z-score distribution for sample population vs. normal population 
for facial width 
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Figure 2. Frequency of z-score distribution probands vs. non-probands for facial width 
 
Figure 3.  Cardiovascular anomalies  
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Figure 4.  Ocular anomalies 
 
Figure 5.  MFS craniofacial features 
 
 
Figure 6.  Morphological height of face  
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Figure 7.  Physiognomical height of the upper face 
 
Figure 8. Mandible height 
 
Figure 9.  Lower face height 
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Figure 10.  Nose height 
 
Figure 11.  Width of nose 
 
Figure 12.  Biocular width 
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Figure 13.  Intercanthal width 
 
Figure 14.  Width of the head 
 
Figure 15.  Width of the forehead 
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Figure 16.  Width of the face 
 
Figure 17.  Width of the mandible 
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APPENDIX 1.  REVISED GHENT NOSOLOGY FOR THE MARFAN SYNDROME 
 
 
                       
 
 
 
